Covidien to transfer manufacturing line to Thailand; Dehaier names interim CFO;

> Covidien ($COV), which employs more than 600 people in County Westmeath in Ireland, is planning to transfer the manufacturing line for one of its products in the area to Thailand. Negotiations on what is termed "voluntary redundancies" have begun, but a company spokesperson says the company is committed to the long-term future of its Athlone plant. Furthermore, it is too early to estimate how many jobs will be lost, the spokesperson added. News

> Dehaier Medical ($DHRM) has reported that Aileen Qi has been appointed interim CFO, effective Oct. 1, after Rita Liu tendered her resignation. Liu resigned to pursue other professional opportunities, the company says. Dehaier release

> DJO Global's Andrew Holman, executive VP, U.S. commercial operations, is leaving the company to explore other prospects. President and CEO Mike Mogul will assume direct responsibility for DJO's commercial activities in the U.S. DJO release

> Terumo Corporation is celebrating its 90th birthday.  Terumo has $4 billion in annual sales and operations in more than 160 countries. Terumo release

> Palmetto GBA, the designated national contractor for Genomic Health's ($GHDX) Oncotype DX colon cancer test, has established a formal coverage policy for all Medicare patients. The test has been clinically validated to predict risk of recurrence in patients with stage II colon cancer. Genomic Health's release

And Finally... Children's Hospital Boston engineers have shown the ability to program the magnetic field generated by a clinical MRI scanner to motorize and control a robotic instrument--in this case, a surgical biopsy needle. Release